Chinese Biotech Could be the Next Major Player in Pharma

Like
Like Love Haha Wow Sad Angry

Chinese Biotech Could be the Next Major Player in Pharma Shanghai Hengrui Pharmaceutical Co., Ltd., a subsidiary of Jiangsu Hengrui Medicine Co., Ltd, is a fully integrated pharmaceutical company in China, with annual net sales of over U.S. $1.4 billion. Hengrui’s products and R&D span over multiple therapeutic areas, such as oncology and hematology, anesthesiology and […]

The post Chinese Biotech Could be the Next Major Player in Pharma appeared first on BioTecNika .Read more at www.biotecnika.org/2018/04/chinese-biotech-could-be-the-next-major-player-in-pharma/

Like
Like Love Haha Wow Sad Angry

Related posts